The George Institute for Global Health was established in 1999 with a mission to improve the health of millions of people worldwide, particularly underserved populations, by challenging the status quo and using innovative approaches to prevent and treat the world’s biggest killers: non-communicable diseases and injury.

With offices in Australia, China, India and the UK, our 700+ people support 245+ active projects and clinical trials across 50+ countries, with 400+ more staff across our social enterprises. We focus on the global health challenges that cause the greatest loss of life, the greatest impairment of life quality and the most substantial economic burden, particularly in resource-poor settings.

Together with our academic partners, UNSW Sydney in Australia, Manipal Academy of Higher Education in India and Imperial College London in the United Kingdom, we work with a global network of collaborators, undertaking clinical, population and health systems research.

Our experts are among the most cited globally, bestowed accolades for excellence and innovation, and regularly participate in policy fora. Our research is published in leading academic journals, referenced in policy documents, and recognised for its excellence, innovation and impact. We are designated a WHO Collaborating Centre (WHO CC) for Injury Prevention & Trauma Care, and a WHO CC for Population Salt Reduction. Since 1999, we have raised more than $1 billion for research and produced over 10,000 peer-reviewed publications and other academic outputs.

The George Institute, China focuses specifically on the biggest health challenges in China. Established in 2007, The George Institute, China has grown into one of the country’s leading health research organisations. With a special focus on health issues affecting the Chinese population and China’s health system, The George Institute, China aims to help address major health issues in China by translating research outcomes into policy and practice, and providing policymakers with effective, high-impact and low-cost evidence.

What we do

• Lead world-class, large-scale clinical trials, epidemiological studies and health systems research to transform treatments and healthcare delivery.
• Look beyond single diseases, across the life course, to identify patient-centred approaches to care that can be implemented at scale.
• Develop low-cost, innovative solutions to global unmet needs.
• Drive our global impact through a program of research, advocacy, thought leadership and disruptive social entrepreneurship.

For more information about The George Institute, visit www.georgeinstitute.org